Laurion Capital Management
AXDX icon

Laurion Capital Management’s Accelerate Diagnostics AXDX Stock Holding History

Laurion Capital Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,140
Closed -$245K – 790
2015
Q4 		$245K Buy
+1,140
New +$208K ﹤0.01% 774

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
JP Morgan Private Wealth Advisors
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Laurion Capital Management's AXDX Position: Q1 2016 in Review

Laurion Capital Management sold out of Accelerate Diagnostics (AXDX) in Q1 2016, closing a stake of 1,140 shares — an estimated $245K sold.

Laurion Capital Management first reported a position in AXDX in Q4 2015 and held it in 1 quarter. The position peaked at $245K in Q4 2015. 92 funds tracked by Wall St. Rank hold AXDX as of Q1 2016.

  • Laurion Capital Management reported no remaining Accelerate Diagnostics position as of Q1 2016 after selling out during the quarter.
  • Laurion Capital Management sold 1,140 Accelerate Diagnostics shares in Q1 2016, an estimated $245K.
  • Laurion Capital Management first reported a position in Accelerate Diagnostics in Q4 2015 and held it in 1 quarter.
  • Laurion Capital Management's Accelerate Diagnostics position peaked at $245K in Q4 2015.
  • 92 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2016.

Based on Laurion Capital Management's 13F filing for Q1 2016, filed 13 May 2016.